<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="51956">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01911130</url>
  </required_header>
  <id_info>
    <org_study_id>2013P000702</org_study_id>
    <nct_id>NCT01911130</nct_id>
  </id_info>
  <brief_title>Longitudinal Study of Outcomes Measures in ALS Trials</brief_title>
  <official_title>Longitudinal Study Comparing the Responsiveness of Outcomes Measures in ALS Trials</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ALS Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A new strength measurement device called Accurate Test of Limb Isometric Strength (ATLIS)
      was developed to precisely and conveniently measure static limb strength in patients with
      ALS. The investigators will compare ATLIS data with data from two commonly used ALS outcomes
      measures, the ALS Functional Rating Scale-Revised (ALSFRS-R) and slow vital capacity (SVC)
      in a prospective, longitudinal study.  All three outcomes measures will be performed on 100
      subjects collected preferably at bi-monthly clinic visits during the study period.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Four sites will participate in data collection for this study and will enroll approximately
      20-30 subjects per site. Subjects will be tested every 1 to 4 months for up to two years.
      Subjects will be tested at each visit using ATLIS, ALSFRS-R questionnaire and slow vital
      capacity testing.

      Inclusion criteria:

        -  Subjects 18 years or older diagnosed with clinically possible, laboratory supported
           probable, probable or clinically definite ALS according to the World Federation of
           Neurology Revised El Escorial Criteria.

        -  Capable of providing informed consent and complying with trial procedures.

      Exclusion criteria:

      -  Patients, judged by the site clinical investigator to have medical conditions that may
      limit their ability to safely exert maximal force using the muscles in their arms and legs
      will be excluded from this study (e.g.  unstable hypertension, significant cardiac disease,
      significant musculoskeletal disorders, or other medical conditions).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Change in Accurate Test of Limb Isometric Strength (ATLIS) between each visit</measure>
    <time_frame>every 1 to 4 months for up to two years</time_frame>
    <safety_issue>No</safety_issue>
    <description>ATLIS measures isometric strength in 12 muscle groups in the arms and legs. The subject is tested seated in a specially designed chairs with adjustable uprights. The subject's limb is placed in a standard position and maximal force is exerted on the wireless load cell fixed to the upright. Strength data is digitally captured and expressed as a percentage of expected normal.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in ALS Functional Rating Scale - Revised (ALSFRS-R) between each visit</measure>
    <time_frame>every 1 to 4 months for up to 2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>This questionnaire consists of 12 questions about the subject's ability to function in certain daily activities. Questions are asked in an interview format.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Slow Vital Capacity (SVC) between each visit</measure>
    <time_frame>Every 1 to 4 months for up to two years</time_frame>
    <safety_issue>No</safety_issue>
    <description>SVC measures the amount of air you can exhale following a deep breath.  For this test, we will ask you to hold a mouthpiece in your mouth, breathe in deeply, and breathe out as much air as you can, up to 5 times.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Amyotrophic Lateral Sclerosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adults with ALS
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years or older

          -  clinically possible, laboartory supported probable, probable or clinically definite
             ALS according to El Escorial Criteria

          -  capable of providing informed consent

        Exclusion Criteria:

          -  persons with medical conditions that would limit their ability to safely exert
             maximal force using muscles in their arms and legs (e.g. unstable cardiac,
             musculoskeletal, or other medical conditions)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patricia L. Andres, DPT, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patricia L. Andres, DPT, MS</last_name>
    <phone>617-724-8995</phone>
    <email>pandres1@partners.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Kentucky</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tony English, PHD, PT</last_name>
      <phone>859-218-0834</phone>
      <email>tenglish@uky.edu</email>
    </contact>
    <contact_backup>
      <last_name>Mary Proffitt</last_name>
      <phone>859 218-0519</phone>
      <email>mkprof0@uky.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Tony English, PhD, PT</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Edward Kasarskis, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Dheel</last_name>
      <phone>617-643-6252</phone>
      <email>cdheel@partners.org</email>
    </contact>
    <investigator>
      <last_name>James Berry, MD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine Siener, PT, MHS</last_name>
      <phone>314-362-8651</phone>
      <email>sienerc@neuro.wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Julaine Florence, DPT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beth Stephens, M.A., CCRC</last_name>
      <phone>717-531-0003</phone>
      <phone_ext>283395</phone_ext>
      <email>hstephens1@psu.edu</email>
    </contact>
    <investigator>
      <last_name>Zachary Simmons, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 16, 2013</lastchanged_date>
  <firstreceived_date>July 10, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Patricia L. Andres</investigator_full_name>
    <investigator_title>Senior Research Scientist</investigator_title>
  </responsible_party>
  <keyword>outcomes measures</keyword>
  <keyword>strength measurement</keyword>
  <keyword>disease progression</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Motor Neuron Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
